• High resolution computed tomography in the diagnosis of idiopathic pulmonary fibrosis 

  Díaz P., Juan Carlos; Palavecino B., Tamara; Pereira R., Gonzalo. Revista Chilena de Enfermedades Respiratorias; Vol. 35 No. 4 (2019): Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019; 268-274

• Appendix 2 

  Unknown author. Revista Chilena de Enfermedades Respiratorias; Vol. 35 No. 4 (2019): Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019

• Appendix 3 

  Unknown author. Revista Chilena de Enfermedades Respiratorias; Vol. 35 No. 4 (2019): Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019

• Adjuvant therapies to antifibrotic therapy in IPF. Importance of multidisciplinary management 

  Undurraga P., Álvaro; Reyes C., Felipe; Velásquez M., José Luis; Azócar B., Claudia; Cabello A., Hernán; Aguayo C., Miguel; Vargas D., Manuel; Maturana S., Daniela; Díaz H., Daniela. Revista Chilena de Enfermedades Respiratorias; Vol. 35 No. 4 (2019): Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019; 293-303

• Multidisciplinary discussion for the diagnosis of idiopathic pulmonary fibrosis 

  Florenzano V., Matías; Reyes C., Felipe; Undurraga P., Álvaro. Revista Chilena de Enfermedades Respiratorias; Vol. 35 No. 4 (2019): Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019; 282-286

• How to monitor patients with idiopathic pulmonary fibrosis? 

  Valenzuela C., Hugo; Reyes H., Mirtha; Pino V., Claudia; Tapia G., Mauricio. Revista Chilena de Enfermedades Respiratorias; Vol. 35 No. 4 (2019): Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019; 304-307

• Acute exacerbations in patients with idiopathic pulmonary fibrosis 

  Morales S., Arturo; Rodríguez D., Juan Carlos. Revista Chilena de Enfermedades Respiratorias; Vol. 35 No. 4 (2019): Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019; 310-312

• 6. Histopathological criteria for the diagnosis of idiopathic pulmonary fibrosis 

  Fernández F., Cristina; Meneses C., Manuel. Revista Chilena de Enfermedades Respiratorias; Vol. 35 No. 4 (2019): Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019; 275-277

• Lung transplant in patients with idiopathic pulmonary fibrosis 

  Briceño V., Catalina; Sepúlveda L., Claudia; Melo T., Joel. Revista Chilena de Enfermedades Respiratorias; Vol. 35 No. 4 (2019): Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019; 308-309

• Rheumatological evaluation of the patient with interstitial lung disease 

  Wolff C., Verónica; Valenzuela L., Omar. Revista Chilena de Enfermedades Respiratorias; Vol. 35 No. 4 (2019): Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019; 278-281

• Pharmacological treatment in the FPI. Disease modifying drugs 

  Florenzano V., Matías; Reyes C., Felipe. Revista Chilena de Enfermedades Respiratorias; Vol. 35 No. 4 (2019): Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019; 287-292

• Appendix 1 

  Unknown author. Revista Chilena de Enfermedades Respiratorias; Vol. 35 No. 4 (2019): Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019

• 2. Definition, pathogenesis and risk factors of idiopathic pulmonary fibrosis 

  Reyes C., Felipe. Revista Chilena de Enfermedades Respiratorias; Vol. 35 No. 4 (2019): Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019; 261-263

• 4. Differential diagnosis of idiopathic pulmonary fibrosis 

  Miranda S., Georgina; Salinas F., Mauricio. Revista Chilena de Enfermedades Respiratorias; Vol. 35 No. 4 (2019): Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019; 266-267

• 1. History and methodology of the first Chilean idiopathic pulmonary fibrosis guidelines, 2019 

  Florenzano V., Matías; Rodríguez C., Francisca. Revista Chilena de Enfermedades Respiratorias; Vol. 35 No. 4 (2019): Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019; 257-260

• How is idiopathic pulmonary fibrosis suspected in primary health care? 

  Faba B., René; Tobar H., Ricardo; Glasinovic B., Valeska; Cerda C., Javier. Revista Chilena de Enfermedades Respiratorias; Vol. 35 No. 4 (2019): Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019; 264-265

• Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019 

  Undurraga P., Álvaro. Revista Chilena de Enfermedades Respiratorias; Vol. 35 No. 4 (2019): Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019; 254-256

• Heated tobacco products with special reference to IQOS 

  Bello S., Sergio. Revista Chilena de Enfermedades Respiratorias; Vol 35 No 3 (2019): Revista Chilena de Enfermedades Respiratorias; 225-231

• Role of bacterial lysates in asthma, evidence and projection with special reference to OM-85 

  Zenteno A., Daniel; Díaz S., Javiera; Quezada L., Arnoldo. Revista Chilena de Enfermedades Respiratorias; Vol 35 No 3 (2019): Revista Chilena de Enfermedades Respiratorias; 219-224

• N/A 

  Oyarzún Gómez, Manuel. Revista Chilena de Enfermedades Respiratorias; Vol 35 No 3 (2019): Revista Chilena de Enfermedades Respiratorias; 232-237

View more